Prof. Sibel Demirel, MD, FEBO is a Full Professor of Ophthalmology and a medical and surgical retina specialist at Ankara University Faculty of Medicine, Türkiye. Her main academic interests are retinal and choroidal imaging, OCT/OCTA, and pachychoroid spectrum diseases, age-related macular degeneration, retinal vascular diseases which constitute a major focus of her scientific publications and international presentations.
She completed an academic training period at the Truhlsen Eye Institute, University of Nebraska Medical Center,USA under the mentorship of Prof. Quan Dong Nguyen. She is a Faculty Member and member of the Operating Committee of European School Advanced Studies in Ophthalmology (ESASO), actively involved in vitreoretinal education and surgical training.
Prof. Demirel has authored and co-authored more than 100 peer-reviewed international publications and has served as an invited speaker, instructor, moderator, and live surgeon at major international retina meetings, including EURETINA, AAO, GIVRE, WOC, FLORETINA, EVRS, ESASO, and the Vit-Buckle Society.

Dr. Lisa J. Faia is currently a Professor of Ophthalmology at the Oakland University William Beaumont School of Medicine and Partner at the Associated Retinal Consultants in Royal Oak, Michigan. She completed her residency in Ophthalmology at Mayo Clinic College of Medicine in Rochester, Minnesota. She completed two fellowships, one at the National Eye Institute at the National Institutes of Health in Bethesda, Maryland in Ocular Immunology and Uveitis and the other at the Associated Retinal Consultants, William Beaumont Hospital, Royal Oak, Michigan in Vitreoretinal Surgery. Her special interests and expertise include proliferative vitreoretinopathy and the surgical and medical management of uveitis. Currently, she is a member of the American Academy of Ophthalmology, Pan-American Academy of Ophthalmology, American Society of Retina Specialists, American Uveitis Society, American Medical Association, Michigan Society of Eye Physicians and Surgeons, Retina Society, Club Jules-Gonin, and Association in Research of Vision and Ophthalmology and has presented nationally and internationally on multiple occasions.

Associate Professor of Ophthalmology, Humanitas University, Milan.

2010: MD Degree (University of Udine, Italy)
2015: Residency in Ophthalmology (Spain)
2017: Vitreo-Retinal research Fellowship. UCLA,Los Angeles, USA.
2019: PhD Degree, University of Alcala', Madrid, Spain.
2020: Vitreo-retinal clinical fellowship, Bristol Eye Hospital, UK.

Grimaldi Ihsan is a Vitreoretina Consultant at National Eye Center Cicendo Eye Hospital Bandung Indonesia. He finished his medical degree at Universitas Padjadjaran Bandung and continue pursuing ophthalmology residency programme at the same university. He continued the vitreoretinal medical and surgical fellowship at National Eye Center Cicendo Eye Hospital Bandung Indonesia and also Rajavithi Hospital as part of his Fellowship Exchange Programme. He also worked at Bandung Eye Center Clinics & Hospital. He also increased his knowledge in medical retina particularly uveitis and retina oncology in LV Prasad Eye Institute. As part of his skill improvement in cataract surgery, he went to Changsa Phacoemulsification Training Camp in China. He also attended several ESASO courses in medical and surgical retina and also uveitis programme.
He is currently appointed as Head Staff of Vitreoretina Services in Cicendo Eye Hospital. He actively participated in hospital transformation programme as part of Ministry of Health initiative programme recently. In 2022, he was awarded by Indonesian Minister of Health for his dedication and loyal services in ophthalmology field. He dedicates himself in vitreoretinal services, research and training medical students, ophthalmology residents and also fellowship programme. He is an active lecturer in Department of Ophthalmology in Universitas Padjadjaran. His areas of expertise include degenerative macular disease, retinal inflammation, retinal vascular disease and vitreoretinal surgery. He published several international and national medical journals and currently active in Cicendo Eye Hospital Research programme. His main interest topics of research are macular degeneration disease, retina imaging, diabetic retinopathy and vitreoretinal surgery. He is keen on improving his knowledge and network globally and locally.
He is regarded as one of key opinion leaders on retinal imaging of Zeiss in Indonesia and also Roche. He actively shares his knowledge in vitreoretinal symposium and workshop in Indonesia and also abroad. He is also active participated in National and International Organization such as Indonesian Ophthalmology Association, INAVRS ( Indonesian Vitreoretina Society ) and Euretina. He participates in vitreoretinal Cicendo fellowship alumni programme and helping other vitreoretinal specialist improving their services and knowledge all across Indonesia. He went all across Indonesia in order to help new graduated vitreoretinal fellow from cicendo eye hospital to implement standardized vitreoretinal services in their hospital.
He actively takes part in CVRE ( Continuing Vitreoretina Education ) programme as part of INAVRS initiative to enhance vitreoretinal services and knowledge all across Indonesia. He is also given mandate as part of Continuing Education Committee in Indonesian Ophthalmology Association.

Professor Dr. Antonia Joussen is a retinal surgeon and Chair of Ophthalmology at Charité University Medicine Berlin, where she heads the ophthalmology clinics at the two Charité campuses, Rudolf Virchow Hospital and Benjamin Franklin Hospital.
After studying medicine in Heidelberg, Vienna, and London, she received her doctorate in Heidelberg in 1996. During her residency in Heidelberg and at RWTH Aachen University, she completed a research fellowship at Boston Children’s Hospital in Massachusetts, USA. In 2000, she held an instructor position at Eye and Ear Massachusetts, Harvard Medical School. Upon returning to Germany, she received funding from the German Research Foundation (DFG) as a junior research group leader through the Emmy Noether Excellence Program from 2002 to 2007.
While establishing her research group on ocular angiogenesis, Professor Joussen completed her residency in retinal surgery under Professor Dr. Bernd Kirchhof at the University Eye Clinic in Cologne. In 2006, after receiving offers of professorships in ophthalmology from the Universities of Regensburg, Göttingen, and Düsseldorf, she decided to continue her work as a professor at the University of Düsseldorf. In Düsseldorf, she was able to deepen her specialization in retinology while simultaneously modernizing the existing focus on corneal diseases at that location. In 2010, she declined a professorship in ophthalmology at the University of Heidelberg and accepted a professorship at Charité University Hospital Berlin.
At Charité, Professor Joussen expanded her focus to include ocular oncology and established the subspecialization of the Charité's Benjamin Franklin Campus in the field of ocular tumor therapy. Professor Joussen continues to conduct active research in the areas of angiogenesis and diabetic retinopathy and has published more than 320 original research articles to date. Singe 2011 she is the editor in Chief of Graefe’s Archives for Clinical and Experimental Ophthalmology, the oldest German ophthalmology journal.

Tengku Ain Kamalden is a Professor at the Department of Ophthalmology, Universiti Malaya, Malaysia, and a vitreoretinal surgeon, clinician-scientist and Fulbright Scholar. She is also affiliated with the UM Eye Research Centre (UMERC). Her clinical and research interests include vitreoretinal disease, diabetic retinopathy, ocular trauma, tear biomarkers and extracellular vesicles, inherited retinal diseases, and translational ophthalmic diagnostics. Her research has explored exosomal microRNAs in diabetic complications and the potential of tear-derived biomarkers for minimally invasive disease detection. She is also actively involved in ophthalmology training, service innovation and international academic collaboration.

Dr. Leo A. Kim, MD, PhD, is an Associate Professor of Ophthalmology at Harvard Medical School and a vitreoretinal surgeon-scientist at Massachusetts Eye and Ear. His research centers on proliferative vitreoretinopathy (PVR), a vision-threatening fibrocontractile complication of retinal detachment repair. His laboratory has identified multiple mechanisms underlying PVR, including inflammatory signaling, cellular phenotypic transitions, fibrosis, Rho kinase?mediated contractility, and has established RUNX1 as a key regulator of PVR-associated pathobiology. Dr. Kim has advanced translational therapeutic approaches to prevent PVR, including methotrexate, Rho kinase inhibition, and targeted RUNX1-inhibitory strategies. His program integrates patient-derived specimens, experimental and ex vivo models, and genomic approaches to develop treatments that prevent retinal fibrosis and improve visual outcomes after complex retinal detachment surgery.

Dr. Ajay E. Kuriyan is a vitreoretinal specialist. He graduated with Honors in dual majors of Biology and Health and Society from University of Rochester, and received his Doctor of Medicine degree, with academic distinction and honors in research, from University of Rochester as well. He then completed an internship at the Mount Sinai Medical Center, and completed his ophthalmology residency at Bascom Palmer Eye Institute, where he was selected as Chief Resident. Dr. Kuriyan also completed his retina fellowship at Bascom Palmer Eye Institute. During his training he was the recipient of numerous prestigious awards including the induction into Alpha Omega Alpha and the Gold Humanism Society, Heed Fellowship, Evangelos S. Gragoudas Award, and the Lee Family Community Service Award.
Dr. Kuriyan is board certified in ophthalmology. He is an active member of the Retina Service at Wills Eye Hospital and is an Associate Professor of Ophthalmology at Sidney Kimmel Medical College of Thomas Jefferson University. He is an innovative surgeon; he performed the first Argus implant surgery in NY state and reported the first case of pre-retinal amniotic membrane for refractory macular holes. He is a member of the American Academy of Ophthalmology, American Society of Retina Specialists, Vit-Buckle Society, Macula Society, Retina Society, and the Association for Research in Vision and Ophthalmology. He serves on several committees and leadership positions for these societies. He has received numerous recognitions for his expertise, including the ASRS’ Presidential Award, Senior Honor Award, and Honor Award, AAO’s Secretariat Award and Achievement Award, Real World Ophthalmology Remarkable Research Award, Ophthalmology Management Top 40 under 40, and Castle Connolly and Philadelphia Magazine Top Doctor recognitions.

Jaeryung Oh, MD, PhD is Professor of Ophthalmology at Korea University College of Medicine, Seoul, Republic of Korea, and a retina specialist with clinical and research expertise in retinal and choroidal diseases. He graduated from Korea University, majored in ophthalmology at the university hospital, and completed research fellow training at the Bascon Palmer Eye Institute in the United States. His academic interests include age-related macular degeneration, pachychoroid spectrum diseases, retinal vascular disorders, and advanced retinal and choroidal imaging, particularly optical coherence tomography (OCT), OCT angiography, and indocyanine green angiography. He has been actively involved in clinical and translational research focusing on the pathophysiology of retinal and choroidal disorders and quantitative analysis of ocular imaging. Dr. Oh currently serves as President of the Korean Retina Society and is actively engaged in academic collaboration and education in the field of retina and vitreous diseases in Korea and internationally.

Dr. Kourous A. Rezaei, M.D., is a highly accomplished and internationally recognized expert in the treatment of both medical and surgical vitreoretinal diseases. His career spans clinical practice, academic leadership, research, and industry innovation.

Key Roles and Accomplishments:

・Academic & Clinical Leadership:

◦Associate Professor of Ophthalmology at Rush University Medical Center.

◦Director of the Vitreoretinal Fellowship at Rush.

◦Senior Partner at Illinois Retina Associates, Chicago.

◦Team ophthalmologist for Chicago Bulls basketball team

・Honors & Recognitions:

◦Inductee, Retina Hall of Fame.

◦Listed among Illinois Top Doctors.

・Innovation & Education:

◦Founder of ChannelR (channelr.net).

◦Course Director for RETINAWS and Formula Retina.

・Professional Society Leadership:

◦Founding Member and Immediate President of the Retina World Congress, currently serving on the Executive Committee.

◦Board Member of EURETINA, leading EURETINA Innovation Spotlight (EIS).

◦Executive Committee Member of EYENOVATE at the Florence Retina Congress (FLORetina).

◦Former Board Member of the American Society of Retina Specialists (ASRS).

・Editorial Contributions:

◦Former Editorial Board Member for:

• ▪Investigative Ophthalmology and Visual Science (IOVS)
• ▪Retina Times (ASRS)
• ▪Retina Today (BMC)
• ▪Eyetube

・Industry Leadership:

◦Former Chief Medical Officer at IVERIC bio, where he led the clinical development of Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration (AMD).

◦Former President and Director at Kalaris Therapeutics Inc, where he lead the IND filing of TH103 as a treatment potential for wet age-related macular degeneration (nAMD).

Dr Daraius Shroff is a vitreoretinal surgeon, the Medical director at Shroff Eye Centre and trustee of the Dr Shroff Charity Eye Hospital (SCEH). He has more than 60 publications in indexed peer reviewed International Journals including articles on innovations in bimanual techniques as well as in advances in Imaging. He was part of the Editorial board of the Indian Journal of Ophthalmology and is a reviewer for prestigious international ophthalmic journals including Retina, Ophthalmology, the American Journal of Ophthalmology, Eye and BMC Ophthalmology.
He won the prestigious Rhett Buckler Award at the American Society of Retina Specialists meeting in San Francisco in 2016 & in Stockholm in 2024 as well as the Vitreoretinal Society of India (VRSI) best video award in 2016. He also won the Buckle for best presentation at the Vit Buckle Society Meeting in Miami in 2024. Dr Shroff is also a part of the Core group of Delhi Retina Forum since its inception.

Adjunct A/Prof. Kelvin Teo is a medical retina subspecialist and Senior Consultant at Advanced Eye Clinic and Surgery, and an Adjunct Associate Professor with the Ophthalmology & Visual Sciences Academic Clinical Programme (EYE ACP), Duke-NUS Medical School. His clinical and research interests include age-related macular degeneration (AMD), diabetic eye disease and retinal vascular conditions.
A graduate of Barts and The London School of Medicine and Dentistry, Dr Teo completed his specialist ophthalmology training at the Singapore National Eye Centre (SNEC), followed by retina fellowships at SNEC and Sydney Eye Hospital. He was awarded his PhD by the University of Sydney for research focused on advancing the management of AMD.
Dr Teo has published over 100 peer-reviewed papers and secured more than SGD 5 million in research funding, including the National Medical Research Council (NMRC) Transition Award. His previous leadership roles include Clinical Director of the SNEC Ocular Reading Centre and Director of the Clinical Trials Platform at the Singapore Eye Research Institute (SERI).
He remains actively involved in advancing retinal research and clinical care in Singapore through the Retina Subspecialty Workgroup of the College of Ophthalmologists, Singapore, and as a member of the SingHealth Centralised Institutional Review Board.

Peng-Tai Tien, MD, PhD, is an Assistant Professor in the School of Medicine at China Medical University and an attending physician specializing in medical and surgical retina at the Eye Center, China Medical University Hospital, Taichung, Taiwan. He received his PhD from the Graduate Institute of Clinical Medical Science at China Medical University and completed a clinical observership with the Retina Service at the Gavin Herbert Eye Institute, University of California, Irvine. At his institution, Dr. Tien serves as Director of the Optometry Unit, Director of the Operating Room and VIP Ward at the Eye & ENT Medical Center, and Deputy Director of the Operating Room for China Medical University Hospital. He currently serves as Secretary General of the Taiwan Retina Society.

Hua Yan, M.D., Ph.D. , currently serves as President-Elect of the Chinese Ophthalmological Society, Vice President of the Chinese Medical Doctor Association Ophthalmologists Branch, and Chief Ophthalmologist at Tianjin Medical University General Hospital. He serves as Vice President of the Asia Pacific Ophthalmic Trauma Society, Fellow of the Academy of Asia-Pacific Professors of Ophthalmology,Fellow, National Academy of Medicine of Brazil and Member of Medical Commission of Association of National Olympic Committees. He is a Full Professor at Tianjin Medical University, Dean of its School of Ophthalmology, and President of the China Ocular Trauma Society. He holds the chairmanship of the Visual Disability Committee of the China Disabled Persons' Federation, and the Shanghai Cooperation Organization National Ophthalmology Alliance. He leads several research institutions, including the International Joint Laboratory of Ocular Diseases, China-UK "Belt and Road" Ophthalmology Joint Laboratory, and the Tianjin Key Laboratory of Ocular Trauma. His research focuses on vitreoretinal diseases, ocular trauma ,and myopia. He has published 419 papers (H-index:27) in journals such as Signal Transduction and Targeted Therapy, Nature Communications, PNAS and Science Translational Medicine ,and edited 21 monographs which included 7series of monographs on ocular trauma published by Springer Press.

Dr. Glenn Yiu is Professor of Ophthalmology at the University of California, Davis, where he is a clinician-scientist and vitreoretinal surgeon. He completed his MD-PhD degrees and residency at Harvard, and vitreoretinal training at Duke, then joined UC Davis in 2014, where he leads a translational research program focusing on gene therapy, ocular imaging, and animal models of retinal disease in mice and nonhuman primates. He also directs the UCD reading center and teleophthalmology program, where he leads a multi-campus collaborative to expand teleretinal diabetic eye screening across California. Dr. Yiu has served on the editorial boards of Scientific Reports and Frontiers in Genome Editing, and has received awards including the Ronald G. Michels Fellowship, the Heed Fellowship, Retina Society Fellowship Research Award, Macula Society Evangelos S. Gragoudas Award, and ARVO Carl Camras Translational Research Award.